Chad Morris, Ph.D., and Jim Pavlik, MA discuss common environmental, psychological, and social factors contributing to increased tobacco use among justice-involved individuals. You’ll learn about an evidence-based intervention model for effectively serving the tobacco cessation needs of justice-involved individuals. Dr. Morris and Mr. Pavlik describe how tobacco cessation for justice-involved individuals can be integrated into a person-centered health neighborhood and identify an actionable short-term goal for integrating tobacco use assessment, brief intervention, and referral to treatment into correctional settings.
Chad Morris, PhD | Jim Pavlik, MA
University of Colorado Behavioral Health & Wellness Program
Video courtesy of National Council for Mental Wellbeing; Behavioral Health & Wellness Program, University of Colorado
Dr. Perez-Stable explores the relationship between tobacco use and the health disparities of minority communities. Dr. Perez-Stable also discusses the biological effects of tobacco use and its interactions with COVID-19. Lastly, Dr. Perez-Stable will discuss how structural determinants and policies affect the delivery of smoking cessation interventions for persons in minority communities.
Eliseo Perez-Stable, MD
Director of the National Institute on Minority Health and Health Disparities and the Smoking Cessation Leadership Center, University of California, San Francisco
Watch this timely video to discover best practices for reaching persons in the LGBTQ+ community who are interested in quitting tobacco.
This webinar explores strategies for providing support in quitting tobacco to persons who have experienced trauma. The importance of fostering resilience as a therapeutic intervention is highlighted.
An Update for Clinicians
This timely webinar examines the public health risks and benefits of e-cigarette use and reviews recent clinical trial data about the risks and efficacy of e-cigarette use for smoking cessation. The presenter, Nancy A. Rigotti, MD from Harvard Medical School, describes evidence-based plans for discussing e-cigarette use with behavioral health members.
Video courtesy of Smoking Cessation Leadership Council, University of California, San Francisco
Comparison of Varenicline, Bupropion & NRT
Chad Morris, Ph.D. explores the benefits of FDA-approved pharmacological treatments for tobacco cessation including varenicline (Chantix™). Dr. Morris reviews the early controversy surrounding the use of bupropion and varenicline and discusses the evidence for current best practices in tobacco cessation medications for individuals with behavioral health disorders.
Video Courtesy of The National Behavioral Health Network for Tobacco & Cancer Control and the Behavioral Health & Wellness Program at the University of Colorado.